Hypopituitarism following radiotherapy

Thames HD, Hendry JH (1987) Response of tissues to fractionated irradiation: effect of repair, in fractionation in radiotherapy. Taylor & Francis, London. pp 53–99

Withers HR (1994) Biology of radiation oncology. In: Tobias JS, Thomas PRM (eds) Current radiation oncology. Edward Arnold, London. pp 5–23

Chieng PU, Huang TS, Chang CC, Chong PN, Tien RD, Su CT (1991) Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients. AJNR Am J Neuroradiol 12:661–665 Medline

Robinson IC, Fairhall KM, Hendry JH, Shalet SM (2001) Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat. J Endocrinol 169:519–526 Medline. doi: 10.1677/joe.0.1690519

Hochberg Z, Kuten A, Hertz P, Tatcher M, Kedar A, Benderly A (1983) The effect of single-dose radiation on cell survival and growth hormone secretion by rat anterior pituitary cells. Radiat Res 94:508–512 Medline. doi: 10.2307/3575908

Constine LS, Woolf PD, Cann D et al (1993) Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 328:87–94 Medline. doi: 10.1056/NEJM199301143280203

Clayton PE, Shalet SM (1991) Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr 118:226–228 Medline. doi: 10.1016/S0022-3476(05)80487-1

Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML (1989) Radiation-induced hypopituitarism is dose-dependent. Clin Endocrinol (Oxf) 31:363–373 Medline

Lam KS, Tse VK, Wang C, Yeung RT, Ho JH (1991) Effects of cranial irradiation on hypothalamic-pituitary function—a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 78:165–176 Medline

Duffner PK, Cohen ME, Voorhess ML et al (1985) Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study. Cancer 56:2189–2193 Medline. doi: 10.1002/1097–0142(19851101)56:92189::AID-CNCR2820560909≥3.0.CO;2-I

Pai HH, Thornton A, Katznelson L et al (2001) Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. J Radiat Oncol Biol Phys 49:1079–1092 doi: 10.1016/S0360-3016(00)01387-0

Samaan NA, Vieto R, Schultz PN et al (1982) Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck. Int J Radiat Oncol Biol Phys 8:1857–1867 Medline

Chen MS, Lin FJ, Huang MJ et al (1989) Prospective hormone study of hypothalamic-pituitary function in patients with nasopharyngeal carcinoma after high dose irradiation. Jpn J Clin Oncol 19:265–270 Medline

Shalet SM, Beardwell CG, Pearson D, Jones PH (1976) The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) 5:287–290 Medline

Brauner R, Czernichow P, Rappaport R (1986) Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia. J Pediatr 108:332 Medline. doi: 10.1016/S0022-3476(86)81027-7

Samaan NA, Schultz PN, Yang KP et al (1987) Endocrine complications after radiotherapy for tumors of the head and neck. J Lab Clin Med 109:364–372 Medline

Ogilvy-Stuart AL, Clark DJ, Wallace WH et al (1992) Endocrine deficit after fractionated total body irradiation. Arch Dis Child 67:1107–1110 Medline

Littley MD, Shalet SM, Morgenstern GR, Deakin DP (1991) Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 78:265–274 Medline

Agha A, Sherlock M, Brennan S et al (2005) Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 90:6355–6360 Medline. doi: 10.1210/jc.2005-1525

Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989) Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70:145–160 Medline

Schmiegelow M, Lassen S, Poulsen HS et al (2000) Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors. Horm Res 54:53–59 Medline. doi: 10.1159/000053232

Spoudeas HA, Hindmarsh PC, Matthews DR, Brook CG (1996) Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study. J Endocrinol 150:329–342 Medline. doi: 10.1677/joe.0.1500329

Achermann JC, Brook CG, Hindmarsh PC (2000) The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiency. Eur J Endocrinol 142:359–364 Medline. doi: 10.1530/eje.0.1420359

Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM (2003) The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 88:95–102 Medline. doi: 10.1210/jc.2002-021094

Brada M, Rajan B, Traish D et al (1993) The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38:571–578 Medline

Rush S, Cooper PR (1997) Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. Int J Radiat Oncol Biol Phys 37:1031–1034 Medline. doi: 10.1016/S0360-3016(96)00586-X

Shalet SM, Beardwell CG, Morris-Jones PH, Pearson D (1975) Pituitary function after treatment of intracranial tumours in children. Lancet 2:104–107 Medline. doi: 10.1016/S0140-6736(75)90006-9

Costin G (1988) Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function. Am J Dis Child 142:847–852

Kirk JA, Raghupathy P, Stevens MM et al (1987) Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet 1:190–193 Medline. doi: 10.1016/S0140-6736(87)90004-3

Brennan BM, Rahim A, Mackie EM, Eden OB, Shalet SM (1998) Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clin Endocrinol (Oxf) 48:777–783 Medline. doi: 10.1046/j.1365-2265.1998.00438.x

Giorgiani G, Bozzola M, Locatelli F et al (1995) Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 86:825–831 Medline

Brauner R, Adan L, Souberbielle JC et al (1997) Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 130:785–792 Medline. doi: 10.1016/S0022-3476(97)80022-4

Papadimitriou A, Urena M, Hamill G, Stanhope R, Leiper AD (1991) Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation. Arch Dis Child 66:689–692 Medline

Olshan JS, Willi SM, Gruccio D, Moshang T Jr (1993) Growth hormone function and treatment following bone marrow transplant for neuroblastoma. Bone Marrow Transplant 12:381–385 Medline

Gleeson HK, Gattamaneni HR, Smethurst L, Brennan BM, Shalet SM (2004) Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy. J Clin Endocrinol Metab 89:662–666 Medline. doi: 10.1210/jc.2003-031224 :

Shalet SM, Toogood AA, Rahim A, Brennan BMD (1998) The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19:203–223 Medline. doi: 10.1210/er.19.2.203

Lustig RH, Schriock EA, Kaplan SL, Grumbach MM (1985) Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency. Pediatrics 76:274–279 Medline

Grossman A, Savage MO, Blacklay A et al (1985) The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature. Horm Res 22:52–57 Medline

Oberfield SE, Kirkland JL, Frantz A, Allen JC, Levine LS (1987) Growth hormone response to GRF 1-44 in children following cranial irradiation for central nervous system tumors. Am J Pediatr Hematol Oncol 9:233–238 Medline. doi: 10.1097/00043426-198724000-00010

Crosnier H, Brauner R, Rappaport R (1988) Growth hormone response to growth hormone-releasing hormone (hp GHRH1-44) as an index of growth hormone secretory dysfunction after prophylactic cranial irradiation for acute lymphoblastic leukemia (24 grays). Acta Paediatr Scand 77:681–687 Medline

Lissett CA, Saleem S, Rahim A, Brennan BM, Shalet SM (2004) The impact of irradiation on growth hormone responsiveness to provocative agents is stimulus dependent: results in 161 individuals with radiation damage to the somatotropic axis. J Clin Endocrinol Metab 86:663–668 Medline. doi: 10.1210/jc.86.2.663

Ahmed SR, Shalet SM, Beardwell CG (1986) The effects of cranial irradiation on growth hormone secretion. Acta Paediatr Scand 75:255–260 Medline

Romshe CA, Zipf WB, Miser A, Miser J, Sotos JF, Newton WA (1984) Evaluation of growth hormone release and human growth hormone treatment in children with cranial irradiation-associated short stature. J Pediatr 104:177–181 Medline. doi: 10.1016/S0022-3476(84)80988-9

Dickinson WP, Berry DH, Dickinson L et al (1978) Differential effects of cranial radiation on growth hormone response to arginine and insulin infusion. J Pediatr 92:754–757 Medline. doi: 10.1016/S0022-3476(78)80143-7

Chrousos GP, Poplack D, Brown T, O’Neill D, Schwade J, Bercu BB (1982) Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics. J Clin Endocrinol Metab 54:1135–1139 Medline

Darzy K, Pezzoli S, Thorner M, Shalet S (2005) The dynamics of GH secretion in adult cancer survivors with severe GH deficiency acquired following brain irradiation in childhood for non-pituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased secretory disorderliness. J Clin Endocrinol Metab 90:2794–2803 Medline. doi: 10.1210/jc.2004-2002

Toogood AA, Nass RM, Pezzoli SS, O’Neill PA, Thorner MO, Shalet SM (1997) Preservation of growth hormone pulsatility despite pituitary pathology, surgery, and irradiation. J Clin Endocrinol Metab 82:2215–2221 Medline. doi: 10.1210/jc.82.7.2215

Reutens AT, Veldhuis JD, Hoffman DM, Leung KC, Ho KK (1996) A highly sensitive growth hormone (GH) enzyme-linked immunosorbent assay uncovers increased contribution of a tonic mode of GH secretion in adults with organic GH deficiency. J Clin Endocrinol Metab 81:1591–1597 Medline. doi: 10.1210/jc.81.4.1591

Baum HB, Biller BM, Katznelson L et al (1996) Assessment of growth hormone (GH) secretion in men with adult-onset GH deficiency compared with that in normal men–a clinical research center study. J Clin Endocrinol Metab 81:84–92 Medline. doi: 10.1210/jc.81.1.84

Roelfsema F, Biermasz NR, Veldhuis JD (2002) Pulsatile, nyctohemeral and entropic characteristics of GH secretion in adult GH-deficient patients: selectively decreased pulsatile release and increased secretory disorderliness with preservation of diurnal timing and gender distinctions. Clin Endocrinol (Oxf) 56:79–87 Medline. doi: 10.1046/j.0300-0664.2001.01433.x

Jessup SK, Malow BA, Symons KV, Barkan AL (2004) Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep. Eur J Endocrinol 151:561–566 Medline. doi 10.1530/eje.0.1510561 :

Ocampo-Lim B, Guo W, DeMott-Friberg R, Barkan AL, Jaffe CA (1996) Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist. J Clin Endocrinol Metab 81:4396–4399 Medline. doi: 10.1210/jc.81.12.4396

Wehrenberg WB, Brazeau P, Luben R, Bohlen P, Guillemin R (1982) Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF). Endocrinology 111:2147–2148 Medline

Darzy KH, Pezzoli SS, Thorner MO, Shalet SM (2007) Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. J Clin Endocrinol Metab 92:1666–1672 Medline. doi: 10.1210/jc.2006-2599

Sklar CA, Constine LS (1995) Chronic neuroendocrinological sequelae of radiation therapy. Int J Radiat Oncol Biol Phys 31:1113–1121 Medline. doi: 10.1016/0360-3016(94)00427-M

Kashio Y, Chihara K, Kita T et al (1987) Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue. J Clin Endocrinol Metab 64:92–97 Medline

Masuda A, Shibasaki T, Hotta M et al (1990) Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man. Regul Pept 31:53–64 Medline. doi: 10.1016/0167-0115(90)90195-3

Koppeschaar HP, ten Horn CD, Thijssen JH, Page MD, Dieguez C, Scanlon MF (1992) Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion. Clin Endocrinol (Oxf) 36:487–490 Medline

Hanew K, Utsumi A (2002) The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. Eur J Endocrinol 146:197–202 Medline. doi: 10.1530/eje.0.1460197

Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717–797 Medline. doi: 10.1210/er.19.6.717

Veldhuis JD, Farhy L, Weltman AL, Kuipers J, Weltman J, Wideman L (2005) Gender modulates sequential suppression and recovery of pulsatile growth hormone secretion by physiological feedback signals in young adults. J Clin Endocrinol Metab 90:2874–2881 Medline. doi: 10.1210/jc.2004-1363

Soares-Welch C, Farhy L, Mielke KL et al (2005) Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults. J Clin Endocrinol Metab 90:2225–2232 Medline. doi: 10.1210/jc.2004-1365

Hoeck HC, Vestergaard P, Jakobsen PE, Laurberg P (1995) Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. Eur J Endocrinol 133:305–312

Diamond MP, Jones T, Caprio S et al (1993) Gender influences counterregulatory hormone responses to hypoglycemia. Metabolism 42:1568–1572 Medline. doi: 10.1016/0026-0495(93)90152-E

Osterman PO, Wide L (1976) The insulin tolerance test after pre-treatment with dexamethasone. Acta Endocrinol (Copenh) 83:341–356 Medline

Biller BM, Samuels MH, Zagar A et al (2002) Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 87:2067–2079 Medline. doi: 10.1210/jc.87.5.2067

Hirvonen E, Seppala M, Karonen SL, Adlercreutz H (1977) Luteinizing hormone responses to luteinizing hormone releasing hormone, and growth hormone and cortisol responses to insulin induced hypoglycaemia in functional secondary amenorrhoea. Acta Endocrinol (Copenh) 84:225–236 Medline

Blatt J, Lee P, Suttner J, Finegold D (1988) Pulsatile growth hormone secretion in children with acute lymphoblastic leukemia after 1800 cGy cranial radiation. Int J Radiat Oncol Biol Phys 15:1001–1006 Medline

Crowne EC, Moore C, Wallace WH et al (1992) A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation. Clin Endocrinol (Oxf) 36:59–68 Medline

Stubberfield TG, Byrne GC, Jones TW (1995) Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation. J Pediatr Hematol Oncol 17:167–171 Medline. doi: 10.1097/00043426-199505000-00012

Lannering B, Rosberg S, Marky I, Moell C, Albertsson-Wikland K (1995) Reduced growth hormone secretion with maintained periodicity following cranial irradiation in children with acute lymphoblastic leukaemia. Clin Endocrinol (Oxf) 42:153–159 Medline

Blatt J, Bercu BB, Gillin JC, Mendelson WB, Poplack DG (1984) Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia. J Pediatr 104:182–186 Medline. doi: 10.1016/S0022-3476(84)80989-0

Moell C, Garwicz S, Westgren U, Wiebe T, Albertsson-Wikland K (1989) Suppressed spontaneous secretion of growth hormone in girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child 64:252–258 Medline

Ryalls M, Spoudeas HA, Hindmarsh PC et al (1993) Short-term endocrine consequences of total body irradiation and bone marrow transplantation in children treated for leukemia. J Endocrinol 136:331–338 Medline

Lannering B, Albertsson-Wikland K (1987) Growth hormone release in children after cranial irradiation. Horm Res 27:13–22 Medline

Moell C (1988) Disturbed pubertal growth in girls after acute leukaemia: a relative growth hormone insufficiency with late presentation. Acta Paediatr Scand Suppl 343:162–166 Medline

Pasqualini T, Escobar ME, Domene H, Muriel FS, Pavlovsky S, Rivarola MA (1987) Evaluation of gonadal function following long-term treatment for acute lymphoblastic leukemia in girls. Am J Pediatr Hematol Oncol 9:15–22 Medline. doi: 10.1097/00043426-198721000-00004

Sanders JE, Buckner CD, Leonard JM et al (1983) Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation. Transplantation 36:252–255 Medline. doi: 10.1097/00007890-198309000-00005

Rappaport R, Brauner R, Czernichow P et al (1982) Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. J Clin Endocrinol Metab 54:1164–1168 Medline

Yoshimoto Y, Moridera K, Imura H (1975) Restoration of normal pituitary gonadotropin reserve by administration of luteinizing-hormone-releasing hormone in patients with hypogonadotropic hypogonadism. N Engl J Med 292:242–245 Medline

Hall JE, Martin KA, Whitney HA, Landy H, Crowley WF Jr (1994) Potential for fertility with replacement of hypothalamic gonadotropin-releasing hormone in long term female survivors of cranial tumors. J Clin Endocrinol Metab 79:1166–1172 Medline. doi: 10.1210/jc.79.4.1166

Brauner R, Rappaport R (1985) Precocious puberty secondary to cranial irradiation for tumors distant from the hypothalamo-pituitary area. Horm Res 22:78–82 Medline

Leiper AD, Stanhope R, Kitching P, Chessells JM (1987) Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Arch Dis Child 62:1107–1112 Medline

Ogilvy-Stuart AL, Clayton PE, Shalet SM (1994) Cranial irradiation and early puberty. J Clin Endocrinol Metab 78:1282–1286 Medline. doi: 10.1210/jc.78.6.1282

Lannering B, Jansson C, Rosberg S, Albertsson-Wikland K (1997) Increased LH and FSH secretion after cranial irradiation in boys. Med Pediatr Oncol 29:280–287 Medline. doi: 10.1002/(SICI)1096-911X(199710)29:4≤280::AID-MPO8≥3.0.CO;2-I

Roth C, Schmidberger H, Schaper O et al (2004) Cranial irradiation of female rats causes dose-dependent and age-dependent activation or inhibition of pubertal development. Pediatr Res 47:586–591 Medline. doi: 10.1203/00006450-200005000-00005

Roth C, Schmidberger H, Lakomek M, Witt O, Wuttke W, Jarry H (2001) Reduction of gamma-aminobutyric acid-ergic neurotransmission as a putative mechanism of radiation induced activation of the gonadotropin releasing-hormone-pulse generator leading to precocious puberty in female rats. Neurosci Lett 297:45–48 Medline. doi: 10.1016/S0304-3940(00)01663-3

Quigley C, Cowell C, Jimenez M et al (1989) Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med 321:143–151 Medline

Livesey EA, Hindmarsh PC, Brook CG et al (1990) Endocrine disorders following treatment of childhood brain tumours. Br J Cancer 61:622–625 Medline

Darzy KH, Shalet SM (2005) Absence of adrenocorticotropin (ACTH) neurosecretory dysfunction but increased cortisol concentrations and production rates in ACTH-replete adult cancer survivors after cranial irradiation for nonpituitary brain tumors. J Clin Endocrinol Metab 90:5217–5225 Medline. doi: 10.1210/jc.2005-0830

Mohn A, Chiarelli F, Di Marzio A, Impicciatore P, Marsico S, Angrilli F (1997) Thyroid function in children treated for acute lymphoblastic leukemia. J Endocrinol Invest 20:215–219 Medline

Lando A, Holm K, Nysom K et al (2001) Thyroid function in survivors of childhood acute lymphoblastic leukaemia: the significance of prophylactic cranial irradiation. Clin Endocrinol (Oxf) 55:21–25 Medline. doi: 10.1046/j.1365-2265.2001.01292.x

Carter EP, Leiper AD, Chessells JM, Hurst A (1989) Thyroid function in children after treatment for acute lymphoblastic leukaemia. Arch Dis Child 64:631 Medline

Oberfield SE, Sklar C, Allen J et al (1992) Thyroid and gonadal function and growth of long-term survivors of medulloblastoma/PNET. In: Green DM, D’Angio GJ (eds) Late effects of treatment for childhood cancer. Wiley-Liss Inc, New York. pp 55–62

Rose SR, Lustig RH, Pitukcheewanont P et al (1999) Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84:4472–4479 Medline. doi: 10.1210/jc.84.12.4472

Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS, Muller J (2003) A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. J Clin Endocrinol Metab 88:136–140 Medline. doi: 10.1210/jc.2002-020380

Darzy KH, Shalet SM (2005) Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. J Clin Endocrinol Metab 90:6490–6497 Medline. doi: 10.1210/jc.2005-1593

Coke C, Andrews DW, Corn BW et al (1997) Multiple fractionated stereotactic radiotherapy of residual pituitary macroadenomas: initial experience. Stereotact Funct Neurosurg 69:183–190 Medline. doi: 10.1159/000099872

Mitsumori M, Shrieve DC, Alexander E III et al (1998) Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 42:573–580 Medline. doi: 10.1016/S0360-3016(98)00256-9

Paek SH, Downes MB, Bednarz G et al (2005) Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 61:795–808 Medline. doi: 10.1016/j.ijrobp.2004.07.688

Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2006) Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 64:542–548 Medline. doi: 10.1111/j.1365-2265.2006.02506.x

Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M (2001) Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 50:1279–1286 Medline. doi: 10.1016/S0360-3016(01)01535-8

Colin P, Jovenin N, Delemer B et al (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 62:333–341 Medline. doi: 10.1016/j.ijrobp.2004.09.058

Hayashi M, Izawa M, Hiyama H et al (1999) Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1):111–118 Medline. doi: 10.1159/000056446

Muacevic A, Uhl E, Wowra B (2004) Gamma knife radiosurgery for nonfunctioning pituitary adenomas. Acta Neurochir Suppl (Wien) 91:51–54

Jane JA Jr, Vance ML, Woodburn CJ, Laws ER Jr (2003) Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14:e12 Medline

Vladyka V, Liscak R, Simonova G et al (2000) [Radiosurgical treatment of hypophyseal adenomas with the gamma knife: results in a group of 163 patients during a 5-year period]. Cas Lek Cesk 139:757–766 Medline

Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD (2002) Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97:408–414 Medline

Kong DS, Lee JI. Lim do H, Kim KW, Shin HJ, Nam DH, Park K, Kim JH (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110:854–860 Medline. doi: 10.1002/cncr.22860

Losa M, Valle M, Mortini P et al (2004) Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100:438–444 Medline

Pollock BE, Carpenter PC (2003) Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas. Neurosurgery 53:1086–1091. discussion 1091–1094 Medline. doi: 10.1227/01.NEU.0000088661.81189.66

Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma Knife surgery for Cushing’s disease. J Neurosurg 106:980–987 Medline

Mingione V, Yen CP, Vance ML et al (2006) Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 104:876–883 Medline

Attanasio R, Epaminonda P, Motti E et al (2003) Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab 88:3105–3112 Medline. doi: 10.1210/jc.2002-021663

Wowra B, Stummer W (2002) Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg 97:429–432 Medline

Jezkova J, Marek J, Hana V et al (2006) Gamma knife radiosurgery for acromegaly–long-term experience. Clin Endocrinol (Oxf) 64:588–595 Medline. doi: 10.1111/j.1365-2265.2006.02513.x

Feigl GC, Bonelli CM, Berghold A, Mokry M (2002) Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97:415–421 Medline

Iwai Y, Yamanaka K, Yoshioka K (2005) Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery 56:699–705. discussion 699–705 Medline. doi 10.1227/01.NEU.0000156836.42945.28 :

Hoybye C, Grenback E, Rahn T, Degerblad M, Thoren M, Hulting AL (2001) Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–291. Discussion 291–292 Medline. doi: 10.1097/00006123-200108000-00008

Vladyka V, Liscak R, Novotny J Jr, Marek J, Jezkova J (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309–316. Discussion 316–317 Medline. doi: 10.1227/01.NEU.0000043709.53906.31 :